Search

Your search keyword '"Matrix Pharmaceutical Inc. -- Research"' showing total 13 results
Start Over Descriptor "Matrix Pharmaceutical Inc. -- Research"
13 results on '"Matrix Pharmaceutical Inc. -- Research"'

1. Sticky ENDs

Subjects
IGEN Inc. -- Product introduction, Formatech -- Management, QIAGEN N.V. -- Management, Guilford Pharmaceuticals Inc. -- Product development, CV Therapeutics Inc. -- Research, BASF AG -- Mergers, acquisitions and divestments, Wyeth -- Mergers, acquisitions and divestments, Pharming Group N.V. -- Management, Baxter Healthcare Corp. -- Management, Millennium Pharmaceuticals Inc. -- Management, Kyowa Hakko Kogyo Company Ltd. -- Management, Matrix Pharmaceutical Inc. -- Research, Celera Corp. -- Reports, Immunicon Corp. -- Research, Therakos Inc. -- Research, Diagnostic reagents industry -- Product introduction, Pharmaceutical industry -- Product development, Biological products industry -- Research, Chemical industry -- Mergers, acquisitions and divestments, Biotechnology industry -- Management, Social services industry -- Research, Biotechnology industry, Business, Berkeley Repertory Theatre (Theater group) -- Reports, Baylor University -- Reports
Abstract

IGEN introduced Infectious Disease Assay Panel for genomic drug targets.

Published
2000

2. Matrix trial for warts drug

Subjects
Matrix Pharmaceutical Inc. -- Research, Pharmaceutical industry -- Research, Business, Business, general
Published
1993

3. MATRIX PHARMACEUTICAL RECEIVES APPROVALS FOR HUMAN CLINICAL TRIALS IN CANCER

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, Matrix Pharmaceutical Inc. -- Research, Pharmaceutical industry -- Research, Business, News, opinion and commentary
Abstract

MATRIX PHARMACEUTICAL RECEIVES APPROVALS FOR HUMAN CLINICAL TRIALS IN CANCER MENLO PARK, Calif., Nov. 18 /PRNewswire/ -- Matrix Pharmaceutical, Inc. today announced the approval of two Investigational New Drug (IND) [...]

Published
1991

4. Clinical trials update

Subjects
Advanced Tissue Sciences Inc. -- Research, Pharmacyclics Inc. -- Research, Matrix Pharmaceutical Inc. -- Research, T Cell Sciences Inc. -- Research, Genzyme Corp. -- Research, Neurogen Corp. -- Research, Biotechnology industry -- Research, Pharmaceutical industry -- Research, Clinical trials -- Reports, Biotechnology industry, Business
Published
1994

5. Progress for Matrix' AccuSite

Subjects
Matrix Pharmaceutical Inc. -- Research, Condyloma acuminatum -- Drug therapy, Pharmaceutical industry -- Research, Business, Pharmaceuticals and cosmetics industries
Published
1994

6. Intradose-FU in prostate cancer

Subjects
Matrix Pharmaceutical Inc. -- Research, Prostate cancer -- Drug therapy, Business, Pharmaceuticals and cosmetics industries, Intradose-FU (Medication) -- Research
Published
1994

7. Matrix Pharmaceutical Inc

Subjects
Matrix Pharmaceutical Inc. -- Research, Cancer -- Care and treatment, Pharmaceutical industry -- Research, Biotechnology industry, Business
Published
1993

8. Matrix' trials with cisplatin implant

Subjects
Matrix Pharmaceutical Inc. -- Research, Pharmaceutical industry -- Research, Clinical trials -- Management, Business, Pharmaceuticals and cosmetics industries
Published
1993

9. International trials in basal cell cancer begin

Subjects
Matrix Pharmaceutical Inc. -- Research, Research, Basal cell carcinoma -- Research, Pharmaceutical industry -- Research
Abstract

The company already has completed Phase III testing with AccuSite for the treatment of genital warts and expects to submit a New Drug Application (NDA) for that indication later in [...]

Published
1995

10. Cancer drug technologies findings presented

Subjects
Matrix Pharmaceutical Inc. -- Research, Research, Drug delivery systems -- Research, Pharmaceutical industry -- Research, Drugs -- Vehicles
Abstract

Matrix Pharmaceutical, Inc., Menlo Park, California, announced the presentation of five cancer research studies involving three of its four proprietary drug delivery technologies at the American Association for Cancer Research [...]

Published
1995

11. Delivery system to make chemotherapy more effective, less toxic

Subjects
Matrix Pharmaceutical Inc. -- Research, Research, Health aspects, Drug delivery systems -- Research -- Health aspects, Collagen -- Health aspects -- Research, Epinephrine -- Health aspects -- Research, Drugs -- Vehicles
Abstract

DATELINE: California Matrix Pharmaceutical Inc. Menlo Park, California, is working on a new drug delivery system that may make current treatments not only hundreds of times more powerful but also [...]

Published
1993

12. Phase II trial of AccuSite gel in patients with SCC skin cancers announced

Subjects
Matrix Pharmaceutical Inc. -- Research, Care and treatment, Research, Skin cancer -- Care and treatment -- Research, Squamous cell carcinoma -- Care and treatment -- Research, Pharmaceutical industry -- Research
Abstract

Matrix Pharmaceutical, Inc., Menlo Park, California, announced that it is conducting a Phase II clinical trial of its AccuSite injectable gel in patients with squamous cell carcinoma (SCC) skin cancers. [...]

Published
1995

13. Matrix initiates Phase II prostate cancer trial

Subjects
Matrix Pharmaceutical Inc. -- Research, Care and treatment, Research, Prostate cancer -- Care and treatment -- Research, Pharmaceutical industry -- Research
Abstract

Matrix Pharmaceutical, Inc., Menlo Park, California, announced the initiation of Phase II clinical testing of its IntraDose-CDDP injectable gel product in patients with prostate cancer. IntraDose-CDDP injectable gel is designed [...]

Published
1995

Catalog

Books, media, physical & digital resources
See catalog results